QUINTA-ANALYTICA
Katerina Bilkova has a strong background in clinical research and operations. Katerina is currently working as the Head of Clinic at QUINTA-ANALYTICA since April 2023. Before that, they worked independently as a Clinical Research Professional starting from August 2022. Prior to their independent work, Katerina held various roles at Premier Research, including Senior Director Clinical Operations (Global) & Country Manager Czech (Local) from July 2020 to July 2022. Katerina also served as Director Clinical Operations (Global) & Country Manager Czech (Local) from January 2020 to June 2020, Director Clinical Monitoring EU (Europe) & Country Manager Czech Republic (Local) from March 2018 to December 2019, and Clinical Research Director (CEE) & Country Manager Czech (Local) from October 2012 to February 2018. Their earlier roles at Premier Research include Clinical Research Manager Czech and Slovak Rep. & Country Manager Czech from November 2011 to September 2012, Clinical Research Manager & Country Manager Czech from April 2007 to October 2011, and Clinical Manager/Project Manager from July 2006 to March 2007. Prior to Premier Research, Katerina worked at IMFORM s.r.o. as a CRA Manager/Clinical Manager from July 2004 to June 2006 and at IMFORM GmbH as a CRA from September 2001 to June 2004.
Katerina Bilkova holds a PhD in biochemistry from the University of Chemistry and Technology in Prague (UCT Prague). No specific start or end year was provided for this education.
This person is not in any teams
QUINTA-ANALYTICA
Quinta is a GCP/GLP/GMP-certified, EMA and FDA-inspected European CRO offering in-house clinical testing, pharmaceutical analysis, CMC and R&D. Quinta specializes in clinical studies, bioanalytics, method development and quality control for both small and large molecules, human and veterinary IMPs as well as generics. We provide unrivaled expertise to worldwide pharmaceutical and biotechnological clients across the entire pharma spectrum. Quinta is part of the Conscio group with headquarters in Munich, Germany, laboratories in Czechia, Austria, Slovakia, Germany and offices in the USA. Our main service areas include: 1) Clinical Testing: With 2 in-house clinical units providing BE/BA/PK studies, with capacity for 60+40 beds. 2) Bioanalytical Testing: GLP/GCP solutions for preclinical & clinical studies, small & large molecules, BE/BA/PK. 3) Research & Development: Analytical R&D, impurities, extractables & leachables, degradation, trace studies. 4) Pharmaceutical Quality Control: GMP quality control, batch testing, stabilities, HAPIs, inhalation, API sourcing. 5) Microbiology: GMP sterile & non-sterile testing, microbial/water analyses, endotoxins, antibiotics & vitamins. 6) Biopharmaceutical Quality Control: GLP/GMP bioanalysis, CMC, characterizations of peptide & protein IMPs, biosimilars. Quinta was founded in 1997 and has been successfully inspected by FDA more than 10 times. Quinta is headquartered in Prague, Czech Republic.